Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 44851-44900 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06476899
A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy
PHASE2
Not yet recruiting
60 participants
Started: Jul 24, 2024 · Completed: Dec 26, 2026
1 condition
1 sponsor
0 locations
NCT06209359
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
PHASE1
Recruiting
50 participants
Started: Jul 24, 2024 · Completed: Mar 1, 2028
2 conditions
2 sponsors
1 location
NCT06442436
A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)
PHASE1
Recruiting
16 participants
Started: Jul 24, 2024 · Completed: Dec 12, 2025
1 condition
1 sponsor
3 locations
NCT06523855
Evaluation of Bilateral Alveolar Cleft Grafting With Micro Plate Stabilization Versus Conventional Grafting Technique
NA
Not yet recruiting
12 participants
Started: Jul 24, 2024 · Completed: Jul 1, 2025
1 condition
1 sponsor
1 location
NCT06972537
A Study on the Infusion Regimen of Piperacillin-Tazobactam in Patients Aged 65 and Older With Pneumonia
NA
Recruiting
42 participants
Started: Jul 24, 2024 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT06491914
A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)
PHASE3
Active, not recruiting
1,118 participants
Started: Jul 24, 2024 · Completed: Jan 7, 2027
2 conditions
1 sponsor
54 locations
NCT06787911
Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer
PHASE2
Recruiting
14 participants
Started: Jul 24, 2024 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT06481969
Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency
NA
Recruiting
260 participants
Started: Jul 23, 2024 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT06764836
A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors
PHASE1
Recruiting
108 participants
Started: Jul 23, 2024 · Completed: Jan 27, 2026
2 conditions
1 sponsor
1 location
NCT06169215
Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma
PHASE2
Recruiting
70 participants
Started: Jul 23, 2024 · Completed: Sep 30, 2026
1 condition
1 sponsor
27 locations
NCT06501846
Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding.
NA
Recruiting
92 participants
Started: Jul 23, 2024 · Completed: Jul 23, 2027
3 conditions
1 sponsor
1 location
NCT06516848
High-intensity Inspiratory Muscle Training in Patients With Asthma
NA
Recruiting
34 participants
Started: Jul 23, 2024 · Completed: Aug 1, 2025
1 condition
1 sponsor
1 location
NCT06239753
The Impact of Dynamic Neuromuscular Stabilization on Pregnancy
NA
Recruiting
144 participants
Started: Jul 23, 2024 · Completed: Jul 2, 2025
2 conditions
1 sponsor
1 location
NCT06578559
Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRC
PHASE2
Recruiting
16 participants
Started: Jul 23, 2024 · Completed: Apr 1, 2027
1 condition
3 sponsors
13 locations
NCT06113016
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
PHASE2
Recruiting
164 participants
Started: Jul 23, 2024 · Completed: Dec 30, 2028
4 conditions
4 sponsors
6 locations
NCT06137807
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
NA
Recruiting
50 participants
Started: Jul 23, 2024 · Completed: Sep 30, 2029
2 conditions
3 sponsors
36 locations
NCT06488755
SIM0718 Treatment of Asthma Clinical Study
PHASE3
Recruiting
418 participants
Started: Jul 23, 2024 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT06351150
Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
PHASE3
Recruiting
214 participants
Started: Jul 23, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
42 locations
NCT06526234
Performance of Non-injected MR Enterography Compared to a Conventional MR Enterography Protocol With Contrast Agent Injection
N/A
Recruiting
500 participants
Started: Jul 23, 2024 · Completed: Jul 23, 2025
1 condition
1 sponsor
1 location
NCT06551831
End-of-life Decision-making Among Young Patients With Advanced Cancer: a Grounded Theory Approach
N/A
Recruiting
30 participants
Started: Jul 23, 2024 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT06551090
Prediction of Anxiety and Memory State
N/A
Recruiting
40 participants
Started: Jul 23, 2024 · Completed: Dec 1, 2026
3 conditions
4 sponsors
1 location
NCT06544915
Evaluating the Effects of a Synbiotic Versus Probiotic or Placebo on Gut Microbiota and Cardiometabolic Health: A Randomized Double-Blind Placebo Controlled Trial
NA
Recruiting
60 participants
Started: Jul 23, 2024 · Completed: Jan 1, 2025
1 condition
1 sponsor
1 location
NCT06112860
OTC Hearing Aid and MCI
NA
Recruiting
50 participants
Started: Jul 23, 2024 · Completed: Dec 31, 2026
3 conditions
1 sponsor
3 locations
NCT06216483
Using EMR Data and AI to Develop a Passive Digital Marker to Predict Postoperative Delirium
NA
Recruiting
60 participants
Started: Jul 23, 2024 · Completed: Feb 11, 2026
1 condition
2 sponsors
1 location
NCT06543368
Low-Cost Platelet-Rich Plasma for Hemarthropathy
NA
Active, not recruiting
20 participants
Started: Jul 23, 2024 · Completed: Jul 1, 2026
2 conditions
1 sponsor
1 location
NCT06410248
Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
PHASE1
Active, not recruiting
30 participants
Started: Jul 23, 2024 · Completed: May 12, 2030
4 conditions
3 sponsors
1 location
NCT05427058
Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management
NA
Recruiting
36 participants
Started: Jul 23, 2024 · Completed: Jan 30, 2026
2 conditions
1 sponsor
1 location
NCT06550245
Babies' Brain Responses to Strangers
N/A
Recruiting
100 participants
Started: Jul 23, 2024 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT06260033
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
PHASE2
Recruiting
18 participants
Started: Jul 23, 2024 · Completed: Oct 29, 2026
3 conditions
2 sponsors
2 locations
NCT06347016
Study of Plozasiran in Adults With Severe Hypertriglyceridemia
PHASE3
Active, not recruiting
311 participants
Started: Jul 23, 2024 · Completed: Sep 30, 2026
1 condition
1 sponsor
149 locations
NCT06427941
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab, in Participants With Advanced or Metastatic Solid Tumors
PHASE1
Recruiting
140 participants
Started: Jul 23, 2024 · Completed: Oct 30, 2026
6 conditions
1 sponsor
15 locations
NCT06098508
Osteopathic Manual Treatment for Hemiplegic Shoulder Pain and Upper Extremity Function in Stroke Patients
NA
Recruiting
10 participants
Started: Jul 23, 2024 · Completed: Feb 28, 2026
2 conditions
1 sponsor
1 location
NCT06349889
Adebrelimab and Chemoradiotherapy in High-risk LANPC
PHASE2
Recruiting
50 participants
Started: Jul 23, 2024 · Completed: May 1, 2028
2 conditions
4 sponsors
4 locations
NCT06284876
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
PHASE3
Recruiting
416 participants
Started: Jul 23, 2024 · Completed: Feb 28, 2027
1 condition
1 sponsor
2 locations
NCT06469801
ECMO ABI Detection With Hyperfine
NA
Recruiting
30 participants
Started: Jul 23, 2024 · Completed: Jul 1, 2026
4 conditions
1 sponsor
1 location
NCT06755775
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
N/A
Recruiting
150 participants
Started: Jul 23, 2024 · Completed: Jul 23, 2029
1 condition
1 sponsor
1 location
NCT06125197
Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer
PHASE1
Recruiting
22 participants
Started: Jul 23, 2024 · Completed: May 30, 2026
1 condition
2 sponsors
2 locations
NCT07197034
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial
PHASE3
Recruiting
90 participants
Started: Jul 23, 2024 · Completed: Apr 30, 2027
3 conditions
1 sponsor
36 locations
NCT06530966
Phase I Study of ICP-332 in Healthy Subjects
PHASE1
Recruiting
24 participants
Started: Jul 23, 2024 · Completed: Dec 25, 2024
1 condition
1 sponsor
1 location
NCT06512116
A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients.
PHASE1
Recruiting
196 participants
Started: Jul 23, 2024 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT06534008
Strive Cardio for Endometrial Cancer Survivors
NA
Active, not recruiting
33 participants
Started: Jul 23, 2024 · Completed: Oct 31, 2025
2 conditions
1 sponsor
1 location
NCT06727461
Effects of FEED@Home Intervention
NA
Enrolling by invitation
180 participants
Started: Jul 23, 2024 · Completed: Sep 30, 2026
2 conditions
1 sponsor
1 location
NCT06412510
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
PHASE1/PHASE2
Recruiting
22 participants
Started: Jul 23, 2024 · Completed: Nov 10, 2025
3 conditions
1 sponsor
1 location
NCT06512064
Acoustic Waveform Respiratory Evaluation
NA
Recruiting
800 participants
Started: Jul 23, 2024 · Completed: Apr 30, 2029
7 conditions
3 sponsors
2 locations
NCT06233045
Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg
PHASE1
Not yet recruiting
30 participants
Started: Jul 23, 2024 · Completed: Sep 8, 2024
1 condition
1 sponsor
0 locations
NCT06434337
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
N/A
Recruiting
600 participants
Started: Jul 23, 2024 · Completed: Mar 31, 2028
1 condition
1 sponsor
1 location
NCT06333314
Dostarlimab for Locally Advanced or Metastatic Cancer (non-colorectal/non-endometrial) with Tumor DMMR/MSI
PHASE2
Recruiting
120 participants
Started: Jul 23, 2024 · Completed: Sep 30, 2030
8 conditions
3 sponsors
22 locations
NCT06587646
VirtuAl Technology to Improve the Management of Perianal Crohn's (VAMP) - PROSPECTIVE
NA
Recruiting
30 participants
Started: Jul 23, 2024 · Completed: Sep 7, 2026
1 condition
1 sponsor
1 location
NCT06401239
Investigating Dyadic Expectations About ARF Survivorship (IDEAS)
N/A
Recruiting
235 participants
Started: Jul 23, 2024 · Completed: Jul 31, 2027
3 conditions
2 sponsors
1 location
NCT06054113
Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
PHASE2
Recruiting
18 participants
Started: Jul 23, 2024 · Completed: Dec 24, 2027
2 conditions
1 sponsor
6 locations
Previous
1
More pages
895
896
897
898
899
900
901
More pages
2369
Next